ROBERT H. LERMAN, MD, PhD
Director of Medicine and Extramural Clinical Research for Metagenics, Inc.
Dr. Lerman is the Director of Medicine and Extramural Clinical Research at Metagenics. Prior to Metagenics, Dr. Lerman was on staff at the Boston University School of Medicine, where he was an Associate Clinical Professor of Medicine and a faculty member in Nutritional Sciences at the Henry M. Goldman School of Graduate Dentistry. He was also Director of Inpatient Nutrition and Director of Clinical Nutrition for more than 15 years at Boston Medical Center, and served as Chief of Nutrition at Jewish Memorial Hospital in Boston. Dr. Lerman is board certified in internal medicine and received his MD from Jefferson Medical College, Philadelphia, Pennsylvania, and a PhD in Nutritional Biochemistry and Metabolism from the Massachusetts Institute of Technology. He has completed fellowships in nephrology and clinical nutrition. As a Major in the U.S. Army Medical Corps, he served as Chief of Medicine at the U.S. Army Hospitals in Berlin, Germany and Vicenza, Italy. In addition, he was acting Chief of Nephrology at Soroka Medical Center in Beer Sheba, Israel.
He has authored and co-authored numerous papers and book chapters, in addition to lecturing on such topics as parenteral nutrition, obesity, fatty acid metabolism, healing and repair of acute myocardial infarction, and trace element deficiency. He is also Director of Medical Education for the Institute for Functional Medicine, serves on the editorial board of Integrative Medicine: A Clinician’s Journal, and an Adjunct Associate Clinical Professor of Medicine at Boston University School of Medicine.
Dr. Lerman’s clinical research activities are centered at Metagenics’ Functional Medicine Research CenterSM, where over the past 4 years he has served as the principle investigator in over 10 studies in such areas as premenstrual syndrome, knee osteoarthritis, fibromyalgia, ex-vivo evaluation of phytonutrient formulations, and evaluation of the effects of a phytonutrient combination on platelet function. In addition, he has been a co-investigator in approximately 10 other studies. He also sees numerous study subjects in individual case management in the evaluation of Metagenics products in a variety of conditions, including metabolic syndrome, diabetes mellitus, hypertension, premenstrual syndrome, perimenopausal hot flashes, fibromyalgia, carbohydrate craving, chronic fatigue syndrome, hypercholesterolemia, rheumatoid arthritis, osteoarthritis, irritable bowel syndrome, and inflammatory bowel disease.